Government coverage of diabetes medications, devices and supplies varies across jurisdictions, leaving some costs for these supports to be borne directly by people living with diabetes in order to effectively manage their disease.

Since 2001, the Canadian Diabetes Association (CDA) has tracked out-of-pocket expenses for Canadians with diabetes using specific composite type 1 and type 2 case studies with low incomes, and compared them across provinces and
territories.

These composite case studies have enabled the CDA to compare and track public drug programs and their ability to support access to diabetes medications, devices and supplies for individuals with similar circumstances.

Report

Donate to diabetes research today!